+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

US Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2019

  • ID: 4790630
  • Report
  • May 2019
  • Region: United States
  • Fore Pharma
1 of 2
The latest research, US Wet Age-Related Macular Degeneration Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Wet Age-Related Macular Degeneration pipeline products, Wet Age-Related Macular Degeneration epidemiology, Wet Age-Related Macular Degeneration market valuations and forecast, Wet Age-Related Macular Degeneration drugs sales and competitive landscape in the US.

The research is classified into seven sections- Wet Age-Related Macular Degeneration treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:
  • Wet Age-Related Macular Degeneration pipeline: Find out the products in clinical trials for the treatment of Wet Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Wet Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Wet Age-Related Macular Degeneration in the US
  • Wet Age-Related Macular Degeneration drugs: Identify key products marketed and prescribed for Wet Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
  • Wet Age-Related Macular Degeneration drugs sales: Find out the sales revenues of Wet Age-Related Macular Degeneration drugs in the US
  • Wet Age-Related Macular Degeneration market valuations: Find out the market size for Wet Age-Related Macular Degeneration drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Wet Age-Related Macular Degeneration drugs market share: Find out the market shares for key Wet Age-Related Macular Degeneration drugs in the US
Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Wet Age-Related Macular Degeneration market analysis and sales trends
  • Track competitor drugs sales and market share in the US Wet Age-Related Macular Degeneration market
  • Track competitive developments in Wet Age-Related Macular Degeneration market and present key issues and learnings
  • Synthesize insights for Wet Age-Related Macular Degeneration market and products to drive business performance
  • Answer key business questions about the Wet Age-Related Macular Degeneration market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Wet Age-Related Macular Degeneration products
  • Supports decision making in R&D to long term marketing strategies

Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1) Wet Age-Related Macular Degeneration Treatments
2) Wet Age-Related Macular Degeneration Pipeline
3) US Wet Age-Related Macular Degeneration Epidemiology
4) Marketed Drugs for Wet Age-Related Macular Degeneration in US
5) US Wet Age-Related Macular Degeneration Market Size and Forecast
6) US Wet Age-Related Macular Degeneration Products Sales and Forecast
7) US Wet Age-Related Macular Degeneration Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Wet Age-Related Macular Degeneration Phase 3 Clinical Trials, 2019
2. Wet Age-Related Macular Degeneration Phase 2 Clinical Trials, 2019
3. Wet Age-Related Macular Degeneration Phase 1 Clinical Trials, 2019
4. Wet Age-Related Macular Degeneration Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Wet Age-Related Macular Degeneration, US, 2018
6. Wet Age-Related Macular Degeneration Market Size and Forecast ($), US, 2014 – 2024
7. Wet Age-Related Macular Degeneration Product Sales ($), US, 2014 – 2024

List of Figures
1. Wet Age-Related Macular Degeneration Epidemiology, US, 2014 - 2024
2. Wet Age-Related Macular Degeneration Market Size and Forecast ($), US, 2014 – 2024
3. Wet Age-Related Macular Degeneration Products Market Share (%), US, 2018
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll